[go: up one dir, main page]

SE9303601D0 - Improved cell cultivation method and medium - Google Patents

Improved cell cultivation method and medium

Info

Publication number
SE9303601D0
SE9303601D0 SE9303601A SE9303601A SE9303601D0 SE 9303601 D0 SE9303601 D0 SE 9303601D0 SE 9303601 A SE9303601 A SE 9303601A SE 9303601 A SE9303601 A SE 9303601A SE 9303601 D0 SE9303601 D0 SE 9303601D0
Authority
SE
Sweden
Prior art keywords
pct
hsa
sec
medium
serum
Prior art date
Application number
SE9303601A
Other languages
English (en)
Inventor
Nilsson Helena Brink
Sarah Boork
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9303601A priority Critical patent/SE9303601D0/sv
Publication of SE9303601D0 publication Critical patent/SE9303601D0/sv
Priority to PCT/SE1994/001023 priority patent/WO1995012663A1/en
Priority to CA 2174533 priority patent/CA2174533A1/en
Priority to NZ275911A priority patent/NZ275911A/en
Priority to FI961848A priority patent/FI961848L/sv
Priority to EP95900342A priority patent/EP0730640A1/en
Priority to US08/632,443 priority patent/US5888815A/en
Priority to AU81192/94A priority patent/AU683104B2/en
Priority to JP51316794A priority patent/JPH09504180A/ja
Priority to NO961749A priority patent/NO961749D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9303601A 1993-11-01 1993-11-01 Improved cell cultivation method and medium SE9303601D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE9303601A SE9303601D0 (sv) 1993-11-01 1993-11-01 Improved cell cultivation method and medium
PCT/SE1994/001023 WO1995012663A1 (en) 1993-11-01 1994-11-01 Improved cell cultivation method and medium
CA 2174533 CA2174533A1 (en) 1993-11-01 1994-11-01 Improved cell cultivation method and medium
NZ275911A NZ275911A (en) 1993-11-01 1994-11-01 Serum-free culture medium suitable for cultivating mammalian cells expressing recombinant factor viii
FI961848A FI961848L (sv) 1993-11-01 1994-11-01 Förbättrat cellodlingsförfarande och -medel
EP95900342A EP0730640A1 (en) 1993-11-01 1994-11-01 Improved cell cultivation method and medium
US08/632,443 US5888815A (en) 1993-11-01 1994-11-01 Cell cultivation method and medium
AU81192/94A AU683104B2 (en) 1993-11-01 1994-11-01 Improved cell cultivation method and medium
JP51316794A JPH09504180A (ja) 1993-11-01 1994-11-01 細胞培養方法および培養媒体
NO961749A NO961749D0 (no) 1993-11-01 1996-04-30 Forbedret celledyrkningsfremgangsmåte og -medium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9303601A SE9303601D0 (sv) 1993-11-01 1993-11-01 Improved cell cultivation method and medium

Publications (1)

Publication Number Publication Date
SE9303601D0 true SE9303601D0 (sv) 1993-11-01

Family

ID=20391605

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9303601A SE9303601D0 (sv) 1993-11-01 1993-11-01 Improved cell cultivation method and medium

Country Status (10)

Country Link
US (1) US5888815A (sv)
EP (1) EP0730640A1 (sv)
JP (1) JPH09504180A (sv)
AU (1) AU683104B2 (sv)
CA (1) CA2174533A1 (sv)
FI (1) FI961848L (sv)
NO (1) NO961749D0 (sv)
NZ (1) NZ275911A (sv)
SE (1) SE9303601D0 (sv)
WO (1) WO1995012663A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2221361A3 (en) 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
US7611896B2 (en) * 1999-12-01 2009-11-03 The United States Of America As Represented By The Secretary Of The Army Practical serological assay for the clinical diagnosis of Leishmaniasis
GB0019415D0 (en) * 2000-08-09 2000-09-27 Ciba Spec Chem Water Treat Ltd Noval monomers, polymers thereof and the use of the polymers
US20060094112A1 (en) * 2001-03-07 2006-05-04 Omotunde Babalola Biological scaffold
WO2002099089A1 (en) * 2001-06-04 2002-12-12 Corixa Corporation Compositions and methods for high-level, large-scale production of recombinant proteins
SI1576182T2 (sl) * 2002-12-23 2020-07-31 Bristol-Myers Squibb Company Izboljšava kvalitete izdelka v procesih pridelave beljakovin v celični kulturi sesalcev
US20160053028A1 (en) * 2013-03-29 2016-02-25 Daiso Co., Ltd. Medium additive for cell culture

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2543158B1 (fr) * 1983-03-24 1985-11-15 Inst Nat Sante Rech Med Milieu de culture de cellules animales sans serum, sans hormones et sans facteurs de croissance et procedes de culture primaire et d'obtention de lignees cellulaires utilisant ce milieu
FI86885C (sv) * 1984-04-20 1992-10-26 Genentech Inc Förfarande för framställning av human rekombinantfaktor VIII och nukle insyrasekvenser och vektorer använd därtill
US4659663A (en) * 1984-10-01 1987-04-21 Board Of Regents, University Of Texas System Methods for isolating cell fusion products
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
DE3709282A1 (de) * 1987-03-20 1988-10-20 Daehn Siegel Sabine Lipidzusatz fuer naehrmedien fuer zell- und gewebekulturen
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
CA2091443A1 (en) * 1990-09-25 1992-03-26 Luciano Ramos Medium for culture of mammalian cells
SE468050C (sv) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII
IL102929A (en) * 1992-08-24 1996-11-14 Interpharm Lab Ltd Serum-free medium for mammalian cells
WO1994011525A1 (en) * 1992-11-17 1994-05-26 Novo Nordisk A/S Improved recombinant production of proteins having factor viii:c activity
SE9300509D0 (sv) * 1993-02-16 1993-02-16 Kabi Pharmacia Ab Peg treatment

Also Published As

Publication number Publication date
FI961848A7 (sv) 1996-04-30
AU8119294A (en) 1995-05-23
EP0730640A1 (en) 1996-09-11
FI961848A0 (sv) 1996-04-30
NZ275911A (en) 1996-12-20
FI961848L (sv) 1996-04-30
US5888815A (en) 1999-03-30
NO961749L (no) 1996-04-30
NO961749D0 (no) 1996-04-30
WO1995012663A1 (en) 1995-05-11
AU683104B2 (en) 1997-10-30
JPH09504180A (ja) 1997-04-28
CA2174533A1 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
Wong et al. Regulation by cytokines and lipopolysaccharide of E-selectin expression by human brain microvessel endothelial cells in primary culture
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
Lillie et al. Fine structure of subcultivated stratified squamous epithelium grown on collagen rafts
Mainardi et al. Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages
NO950534D0 (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
WO2003039232A3 (en) Endothelial cell derived hemotopoietic growth factor
AR020735A1 (es) Un procedimiento para la obtencion de un polipeptido glucosilado a partir de celulas eucarioticas
FI844597L (fi) Foerfarande foer framstaellning av en synnerligen ren hyaluronsyra.
ATE464386T1 (de) Verfahren zur herstellung sekretierter proteine
DE69031732D1 (de) Verfahren zur herstellung von glykosid-estern und zusammensetzungen daraus
SE9303601D0 (sv) Improved cell cultivation method and medium
DE59610632D1 (de) Varianten des humanen rekombinanten interferon-gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DE69416166D1 (de) Verfahren zur regulierung von sialinsaeurederivaten in rekombinanten glykoproteinen
ATE127846T1 (de) Herstellung von hv/hb copolymer.
EP0067697B1 (en) Cell culture method
DE69014046D1 (de) Verzweigungsenzym und dessen Verwendung.
DE3271820D1 (en) Fully synthetic cell culture medium
FI894001A0 (fi) Vaextgummimaterial och dess anvaendning i livsmedelsprodukter.
ATE170924T1 (de) Verfahren zur veresterung von carbonsäuren mit tertiären alkoholen
Kishi et al. Synthesis of latent collagenase and collagenase inhibitor by bovine aortic medial explants and cultured medial smooth muscle cells
AUPM772494A0 (en) Improvements in production of proteins in host cells
ATE180837T1 (de) Verfahren zur herstellung von häm-proteinen
Bomalaski et al. Rheumatoid arthritis synovial fluid phospholipase A2 activating protein (PLAP) stimulates human neutrophil degranulation and superoxide ion production
AU6733896A (en) Transferrin glycans composition for the induction of immune tolerance
DE69405877D1 (de) Oberflächenaktive mittel